Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.89M Buy
300,666
+7,489
+3% +$134K 0.01% 589
2026
Q1
$5.58M Buy
293,177
+3,200
+1% +$61.8K 0.01% 584
2025
Q4
$4.75M Buy
289,977
+23,872
+9% +$420K 0.01% 602
2025
Q3
$5M Sell
266,105
-1,943
-0.7% -$34.8K 0.01% 599
2025
Q2
$5.41M Buy
268,048
+10,892
+4% +$188K 0.01% 584
2025
Q1
$3.54M Buy
257,156
+4,356
+2% +$60K 0.01% 557
2024
Q4
$3M Buy
252,800
+5,900
+2% +$92.9K 0.01% 578
2024
Q3
$4.43M Buy
+246,900
New +$4.5M 0.01% 490

Other funds holding XP

Aviva's XP Position: Q2 2026 in Review

Aviva increased its XP (XP) stake by 2.6% in Q2 2026, buying an estimated $134K and bringing the position to 300,666 shares worth $4.89M. The position accounts for 0.01% of the portfolio, ranked #589.

Aviva first reported a position in XP in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.58M in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Aviva held 300,666 shares of XP worth $4.89M as of Q2 2026.
  • Aviva bought 7,489 XP shares in Q2 2026, an estimated $134K.
  • XP made up 0.01% of Aviva's portfolio in Q2 2026, its #589 holding.
  • Aviva first reported a position in XP in Q3 2024 and has held it in 8 quarters since.
  • Aviva's XP position peaked at $5.58M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.